Filing metadata

Accession number
0001209191-21-023039
Form type
Form 4
Filer
ENDRA Life Sciences Inc.
CIK
CIK 1681682
Filed
Mar 25, 2021
Reporting period
Jan 04, 2021
Description
Insider transaction

Explore SEC Filings Hub